Recommendations for the use of Japanese encephalitis vaccines
Journal
Pediatrics and Neonatology
Journal Volume
61
Journal Issue
1
Pages
3-8
Date Issued
2020
Author(s)
Huang Y.-C.
Hwang K.-P.
Liu C.-C.
Chiu C.-H.
Chen P.-Y.
Chen C.-J.
Chiu N.-C.
Chi H.
Lin H.-C.
Wu K.-G.
Ho Y.-H.
Sun W.
Lin T.-Y.
Abstract
Japanese encephalitis (JE) is a mosquito-borne viral infection which is prevalent in Taiwan. The virus circulates in an enzootic cycle in pigs which serve as amplifying hosts. Outbreaks typically occur during summer. A universal vaccination program using 4-shot mouse brain-derived inactivated vaccine has successfully controlled JE epidemics in Taiwan since 1968. More than 90% of JE cases in recent years were older than 20 years in Taiwan. Because of several drawbacks, mouse brain-derived vaccine has been replaced by newer generation JE vaccines, including inactivated Vero cell-derived vaccine and live chimeric vaccine. The present article describes the recommendations in Taiwan for the use of new JE vaccines and the schedules for shifting between different JE vaccines. ? 2019
SDGs
Other Subjects
inactivated vaccine; Japanese encephalitis vaccine; live vaccine; inactivated vaccine; Japanese encephalitis vaccine; human; Japanese encephalitis; Japanese encephalitis virus; nonhuman; practice guideline; Review; Taiwan; vaccination; Vero cell line; virus transmission; immunology; Japanese encephalitis; Encephalitis, Japanese; Humans; Japanese Encephalitis Vaccines; Taiwan; Vaccination; Vaccines, Inactivated
Publisher
Elsevier (Singapore) Pte Ltd
Type
review